Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teslexivir 5% Gel in Condyloma Patients
NCT02724254Phase 2Completed
- Sponsor
- Vaxart, Inc.
- Start
- Jan 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of teslexivir in condyloma acuminata, sponsored by Vaxart, Inc.. Started Jan 2016; status: completed.
02
Drugs
teslexivir
03
Conditions
condyloma acuminata
Beyond the preview
Go deeper on NCT02724254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724254.